Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CVRx, Inc. (CVRX : NSDQ)

• Company Description    CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN. Number of Employees: 223

• Price / Volume Information    Yesterday's Closing Price: $1.55 Daily Weekly Monthly 20 Day Moving Average: 763,470 shares Shares Outstanding: 26.64 (millions) Market Capitalization: $41.29 (millions) Beta: 0.77 52 Week High: $11.30 52 Week Low: $1.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -49.18% -49.21% 12 Week -71.46% -72.00% Year To Date -78.17% -80.65%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9201 WEST BROADWAY AVENUE SUITE 650 - MINNEAPOLIS,MN 55445 USA ph: 763-416-2840 fax: 763-416-2841 ir@cvrx.com http://www.cvrx.com

• General Corporate Information    Officers Kevin Hykes - Chief Executive Officer and President Jared Oasheim - Chief Financial Officer Kevin Ballinger - Director Mitch Hill - Director Mudit Jain - Director Peer Information CVRx, Inc. (ABMD) CVRx, Inc. (DMDS) CVRx, Inc. (CPWY.) CVRx, Inc. (EQUR) CVRx, Inc. (ECIA) CVRx, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 126638105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 26.64 Most Recent Split Date: (:1) Beta: 0.77 Market Capitalization: $41.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.48 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.07 Price/Cash Flow: - Price / Sales: 0.67 EPS Growth vs. Year Ago Period: 7.02% vs. Previous Quarter: -6.00% Sales Growth vs. Year Ago Period: 15.57% vs. Previous Quarter: 6.34% ROE 09/30/26 - - 06/30/26 - -152.35 03/31/26 - -120.76 ROA 09/30/26 - - 06/30/26 - -50.93 03/31/26 - -48.38 Current Ratio 09/30/26 - - 06/30/26 - 8.04 03/31/26 - 10.20 Quick Ratio 09/30/26 - - 06/30/26 - 6.87 03/31/26 - 8.89 Operating Margin 09/30/26 - - 06/30/26 - -84.93 03/31/26 - -89.14 Net Margin 09/30/26 - - 06/30/26 - -84.93 03/31/26 - -89.14 Pre-Tax Margin 09/30/26 - - 06/30/26 - -84.94 03/31/26 - -89.17 Book Value 09/30/26 - - 06/30/26 - 0.75 03/31/26 - 1.10 Inventory Turnover 09/30/26 - - 06/30/26 - 0.65 03/31/26 - 0.68 Debt-to-Equity 09/30/26 - - 06/30/26 - 2.94 03/31/26 - 2.01 Debt-to-Capital 09/30/26 - - 06/30/26 - 74.59 03/31/26 - 66.77

Powered by Zacks Investment Research ©